The trusted source for
healthcare information and
During this program our Presenter discusses the definition, classification and diagnostic work up to differentiate subgroups of pulmonary hypertension with focus of pulmonary arterial hypertension (PAH). Treatment options for pulmonary arterial hypertension has evolved and patients with PAH are living longer on these therapies. However, there exists a knowledge gap in current medical practice which causes delay in diagnosis which can potentially increase morbidity and mortality from PAH. With this course Dr. Shah narrows the knowledge gap and helps providers identify this disease earlier to ensure early initiation of treatment. Also covers pulmonary arterial hypertension (PAH) and different conditions that cause PAH. Our Presenter reviews common presenting signs/symptoms, diagnostic work up and treatment in a case based approach. Additionally discussing the role of referring providers in care of PAH patients and various options out there to effectively treat patient.
Dr. Trushil Shah has no relevant financial or non-financial relationships to disclose that is related to this educational activity. The planners of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.
ANCC: Relias LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Contact hours [1.0] will be awarded to participants who meet the criteria for successful completion. California Board of Registered Nursing, Provider CEP#13791.
ACCME: Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Relias LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CE activity available for streaming on April 28th, 2020
This CE activity is valid until April 28th, 2023